Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
about
Incidence, risk factors and outcomes of de novo malignancies post liver transplantationRole of EBNA-3 Family Proteins in EBV Associated B-cell LymphomagenesisBurden of de novo malignancy in the liver transplant recipientEpigenetic impact of infection on carcinogenesis: mechanisms and applicationsEpigenetic Impact on EBV Associated B-Cell LymphomagenesisEpstein-Barr Virus: Diseases Linked to Infection and TransformationLymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processesEarly response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan.E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.EBV-associated lymphomas in adultsFunctional modulation of the metastatic suppressor Nm23-H1 by oncogenic virusesEpstein-Barr virus-positive T/NK-cell lymphoproliferative disordersPlasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma.Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.Posttransplant lymphoproliferative disease after lung transplantation.The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion.An essential role for γ-herpesvirus latency-associated nuclear antigen homolog in an acute lymphoproliferative disease of cattleActivation of human herpesvirus replication by apoptosisExo-miRExplorer: A Comprehensive Resource for Exploring and Comparatively Analyzing Exogenous MicroRNAs.Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.Modes of infection and oncogenesis by the Epstein-Barr virus.Role of epigenetics in EBV regulation and pathogenesis.Regulation of the metastasis suppressor Nm23-H1 by tumor viruses.Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells.Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.Epstein-Barr virus latency: current and future perspectives.An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation.RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.Visual detection and evaluation of latent and lytic gene expression during Epstein-Barr virus infection using one-step reverse transcription loop-mediated isothermal amplification.Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.Persistent Organic Pollutant and Hormone Levels in Harbor Porpoise with B Cell Lymphoma.Investigation on the association between thyroid tumorigeneses and herpesviruses.Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.Natural killer T cell strategies to combat Epstein-Barr virus infection.EBV-Associated Cancer and Autoimmunity: Searching for Therapies.
P2860
Q26748580-6263040B-1B3D-4CA7-8481-FD34A2E2D3F7Q26752541-07DE88CE-543D-43AE-9E9F-F8967999CA57Q26859216-F4143467-D14A-4DE1-9C9D-B53CE62E5FA4Q28066519-B56FFBC6-0E85-49E8-A030-3C90A4A9F623Q28068361-D82303E1-1E36-4AA4-96CC-8F129D59BECDQ28074586-FE7983F7-2507-498C-B717-077A96AB854FQ28271456-E1D20643-7429-4979-9096-27ABABA5D9B5Q33409443-C63C612B-08A4-4B77-A9DF-3EF5A84A9588Q33595456-7D486A0F-97B0-4501-B4AE-94BB302D6550Q34205875-603DE582-56A6-4963-B490-552BBE149F9BQ34636601-C1D242CB-6268-4578-A2E9-F9054266E4C0Q34901718-666E88F5-4BE0-4CA4-9209-D63804368A23Q35040638-B18C9612-2C17-4543-9B22-818B3094263EQ35961549-247012D3-8AEA-4DA9-AB6C-33B28C8C9361Q36079181-83DCC6C0-A6DA-433F-B6C0-0499C1E38069Q36434206-424A185E-FB2D-45CB-B0CA-E3A007F5760DQ36701511-4EC4DDE9-489D-4C42-9BDE-FB1FBE2330DBQ36872499-763539D9-2ADE-4958-B655-4528E9E17D41Q36884039-C39EFCC6-EE47-421D-8E5D-22EDB1A0F102Q37252864-970A8854-CB63-4CB6-90E8-B57A83CF8301Q37617426-50C9440A-57DC-4194-80D2-97021C73DBC2Q38086861-C086618F-4082-4732-A91B-2FABFC2E36B5Q38133428-A8B147C3-BDED-4F19-AA4F-C05DA94CF8E5Q38186800-8BEF91A6-A18F-458A-9D91-94A239497F39Q38191876-DA2F00A5-A95F-4E14-9570-2C0F8529E7B3Q38232195-FBBCA08E-2610-49B8-97BF-B261FA05B514Q38246971-986D4B2F-21CB-446A-B535-61A3BE96C624Q38315444-5AB36A20-22EA-4C78-AEE9-401E9A12147EQ38321333-56195950-2332-4A0A-BCBE-A83DD0216A24Q38603533-AE5110FB-C6A1-4C72-846B-E394B0C01254Q38664787-B1017223-54E1-465A-A553-0E80B77C9FACQ38793717-21B47B8F-C50D-436F-96C4-48A472871809Q39042093-4E60947E-4FC3-4B0F-8BF9-771AEAD829B1Q39140011-CD050C04-6B16-406F-8D6C-778632E3D8C9Q39226853-710233C3-096F-43AE-91D9-D33884F85A75Q40226058-301DCB1A-A84D-45EA-A1D5-A374FD7230EEQ40300872-C314B8B2-7D65-4BD6-8144-78496DBAB2E9Q40876736-F103818D-58E2-48EC-8C3B-8056E623B84BQ40878053-353800F7-490C-4E90-A9AC-AB709F3A9CCEQ41012612-29B20F3A-026A-4BE0-A0D6-705C2375A14E
P2860
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@en
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@nl
type
label
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@en
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@nl
prefLabel
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@en
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@nl
P2860
P1476
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
@en
P2093
Abhik Saha
P2860
P304
P356
10.1158/1078-0432.CCR-10-2578
P407
P577
2011-03-03T00:00:00Z